- Home
- MITK vs TSHA Comparison
MITK vs TSHA Comparison
Compare MITK & TSHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MITK
- TSHA
- Stock Information
- Founded
- MITK 1983
- TSHA 2019
- Country
- MITK United States
- TSHA United States
- Employees
- MITK N/A
- TSHA N/A
- Industry
- MITK Computer peripheral equipment
- TSHA Biotechnology: Pharmaceutical Preparations
- Sector
- MITK Technology
- TSHA Health Care
- Exchange
- MITK Nasdaq
- TSHA Nasdaq
- Market Cap
- MITK 440.3M
- TSHA 403.7M
- IPO Year
- MITK N/A
- TSHA 2020
- Fundamental
- Price
- MITK $11.43
- TSHA $1.85
- Analyst Decision
- MITK Strong Buy
- TSHA Strong Buy
- Analyst Count
- MITK 4
- TSHA 8
- Target Price
- MITK $12.63
- TSHA $6.63
- AVG Volume (30 Days)
- MITK 833.9K
- TSHA 4.9M
- Earning Date
- MITK 12-16-2024
- TSHA 11-13-2024
- Dividend Yield
- MITK N/A
- TSHA N/A
- EPS Growth
- MITK N/A
- TSHA N/A
- EPS
- MITK 0.07
- TSHA N/A
- Revenue
- MITK $172,083,000.00
- TSHA $9,915,000.00
- Revenue This Year
- MITK $6.41
- TSHA N/A
- Revenue Next Year
- MITK $11.24
- TSHA N/A
- P/E Ratio
- MITK $163.29
- TSHA N/A
- Revenue Growth
- MITK N/A
- TSHA N/A
- 52 Week Low
- MITK $7.35
- TSHA $1.19
- 52 Week High
- MITK $16.24
- TSHA $4.32
- Technical
- Relative Strength Index (RSI)
- MITK 75.15
- TSHA 38.54
- Support Level
- MITK $8.58
- TSHA $1.80
- Resistance Level
- MITK $11.56
- TSHA $2.72
- Average True Range (ATR)
- MITK 0.48
- TSHA 0.23
- MACD
- MITK 0.25
- TSHA -0.10
- Stochastic Oscillator
- MITK 95.64
- TSHA 3.81
About MITK Mitek Systems Inc.
Mitek Systems Inc is engaged in the development, sale, and service of proprietary software solutions related to mobile imaging. The firm is a software development company with expertise in artificial intelligence, and machine learning. It is serving more than 7,800 financial services organizations and leading marketplace and financial technology brands across the globe. Mitek's Mobile Deposit solution is used by consumers for mobile check deposits. The company's Mobile Verify verifies a user's identity online enabling organizations to build safer digital communities, whereas CheckReader enables financial institutions to automatically extract data from a check image received across any deposit channel - branch, ATM, RDC, and mobile.
About TSHA Taysha Gene Therapies Inc.
Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.